Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPROBAMATE vs MEROPENEM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPROBAMATE vs MEROPENEM: Safety Overview

Metric MEPROBAMATE MEROPENEM
Total FAERS Reports 427 13,867
Deaths Reported 320 3,880
Death Rate 74.9% 28.0%
Hospitalizations 55 7,167
Average Patient Age 44.8 yrs 51.1 yrs
% Female Patients 54.6% 42.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 12, 2016
Manufacturer Cipla USA Inc. Eugia US LLC
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued